News

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...
Bengaluru, created an affordable, portable device for preliminary screening of Sickle Cell Disease (SCD). Led by Prof Gautam ...
Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...
For adults with sickle cell disease, C-reactive protein levels increase significantly during the follicular phase of the menstrual cycle.
Sickle Cell Disease ... managing the disease and improving quality of life. Why are individuals with SCD more susceptible to infections? One of the most critical complications of SCD is functional ...
2 Department of Pathology and ... the brunt of the disease, resulting in diffuse alveolar damage (DAD), many other organs, including the heart, the kidneys, the hepatobiliary system, the central ...
We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...
This work demonstrated that blocking signaling pathways reduced plasma cell accumulation and alleviated lung scarring. Targeting these same signaling pathways may thus prove an effective disease ...
Cohen Children’s Medical Center treats about 600 children with sickle cell disease. Doctors say roughly 100,000 people live with the condition in the U.S., and millions more worldwide.
The potential target, the FLT1 gene, contributes to the production of a protein, fetal hemoglobin, whose presence is already known to improve the lifespan of people with sickle cell disease.
“The cliche ‘the future is here’ is actually true in this case,” said Dr. Charles Schleien, from Cohen Children’s Medical Center, per NBC News “Sickle cell disease was described in ...
Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that affects about 300,000 people globally each year, with limited treatment options ...